International Atherosclerosis Society

International Atherosclerosis Society
Name	International Atherosclerosis Society
Type	Nonprofit organization
Founded	1964
Headquarters	Geneva, Switzerland
Region served	Worldwide
Focus	Atherosclerosis, cardiovascular prevention, lipidology
Leader title	President

Contents

International Atherosclerosis Society The International Atherosclerosis Society is a global professional association focused on cardiology, vascular medicine, lipidology, and the prevention of atherosclerosis. It convenes clinicians, researchers, and public health leaders from institutions such as World Health Organization, Johns Hopkins Hospital, Mayo Clinic, Imperial College London, and Karolinska Institutet to translate scientific discoveries into policy and practice. The Society collaborates with specialty organizations like European Society of Cardiology, American Heart Association, National Institutes of Health, European Atherosclerosis Society, and International Society of Hypertension.

History

The Society was established in the context of mid‑20th century advances in cardiovascular disease research and the epidemiologic transition documented by investigators at Framingham Heart Study, Harvard Medical School, and Stanford University. Early leadership included clinicians affiliated with Royal Brompton Hospital, Cleveland Clinic, Toronto General Hospital, and University of Oxford. Landmark events in its development paralleled discoveries at National Heart, Lung, and Blood Institute, trials such as those led by British Heart Foundation, and collaborations with agencies including European Commission and United Nations. Over successive decades the Society expanded networks to centers like John Radcliffe Hospital, Guy's and St Thomas' NHS Foundation Trust, University of California, San Francisco, and Peking University Health Science Center.

The Society's mission aligns with priorities set by World Health Assembly resolutions and clinical guidance from bodies such as American College of Cardiology, European Medicines Agency, National Institute for Health and Care Excellence, and International Council of Nurses. Core objectives include advancing research at institutions like Massachusetts General Hospital and Singapore General Hospital, promoting guideline development with partners such as Canadian Cardiovascular Society, supporting capacity building in regions represented by Pan American Health Organization and African Union, and disseminating evidence through collaborations with organizations like Royal College of Physicians.

Governance follows structures comparable to academies such as National Academy of Medicine and societies including Royal Society. The executive board and scientific committee include representatives from Johns Hopkins University, University of Cambridge, University of Tokyo, University of São Paulo, and University of Melbourne. Advisory panels feature experts from World Bank health programs, nonstate actors like Clinton Health Access Initiative, and specialty groups such as European Society of Hypertension and International Diabetes Federation. Regional chapters coordinate with health ministries of countries like United Kingdom, United States, China, India, and Brazil.

Programs mirror initiatives by Global Alliance for Chronic Diseases and training schemes used by Royal College of Surgeons. Activities include multicenter clinical collaborations modeled on trials from ClinicalTrials.gov registries, educational fellowships supported by foundations such as Wellcome Trust and Gates Foundation, guideline development informed by panels akin to U.S. Preventive Services Task Force, and capacity building projects in partnership with Centers for Disease Control and Prevention. The Society administers mentorship schemes drawing faculty from University of Oxford and Yale School of Medicine.

The Society fosters research networks comparable to consortia like Global Burden of Disease and collaborates with journals and publishers associated with The Lancet, New England Journal of Medicine, Journal of the American College of Cardiology, European Heart Journal, and Circulation Research. It sponsors systematic reviews and meta‑analyses in venues used by researchers at McMaster University, Columbia University Irving Medical Center, University of Toronto, and Seoul National University Hospital. Data-sharing initiatives align with standards promoted by International Committee of Medical Journal Editors and repositories supported by National Library of Medicine.

The Society organizes biennial congresses modeled after meetings such as European Society of Cardiology Congress, American Heart Association Scientific Sessions, and symposia held at institutions like Karolinska Institute and Johns Hopkins University School of Medicine. Educational activities include workshops, webinars, and certification programs developed with partners such as European Board for Accreditation in Cardiology and universities like University of California, Los Angeles. Satellite events and joint sessions feature speakers from Massachusetts Institute of Technology, ETH Zurich, University College London, and Monash University.

Advocacy work is conducted in concert with stakeholders including World Heart Federation, UNICEF, World Bank Group, and national agencies such as Centers for Disease Control and Prevention and Public Health England. Partnerships extend to professional organizations like American Society for Clinical Investigation, International Atherosclerosis Society Research Network, Global Heart Network, and funders including European Research Council, National Science Foundation, and philanthropic entities such as Rockefeller Foundation. The Society engages in policy dialogues at venues like United Nations General Assembly and regional forums including ASEAN Summit and African Union Summit.

Category:Cardiology organizations Category:Medical associations